Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4HOFFMANN-LA ROCHE LIMITED

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

EMICIZUMAB

Brand Name : HEMLIBRA

Dosage Form : SOLUTION

Dosage Strength : 30MG/1ML

Packaging : 1ML

Approval Date :

Application Number : 2479621

Regulatory Info : Prescription

Registration Country : Canada

blank

02

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

EMICIZUMAB

Brand Name : HEMLIBRA

Dosage Form : SOLUTION

Dosage Strength : 60MG/0.4ML

Packaging : 0.4ML

Approval Date :

Application Number : 2479648

Regulatory Info : Prescription

Registration Country : Canada

blank

03

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

EMICIZUMAB

Brand Name : HEMLIBRA

Dosage Form : SOLUTION

Dosage Strength : 105MG/0.7ML

Packaging : 0.7ML

Approval Date :

Application Number : 2479656

Regulatory Info : Prescription

Registration Country : Canada

blank

04

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

EMICIZUMAB

Brand Name : HEMLIBRA

Dosage Form : SOLUTION

Dosage Strength : 150MG/ML

Packaging :

Approval Date :

Application Number : 2479664

Regulatory Info : Prescription

Registration Country : Canada

blank